tiprankstipranks
Bal Pharma Limited (IN:BALPHARMA)
:BALPHARMA
India Market
BALPHARMA
Bal Pharma Limited
RESEARCH TOOLSreports
Want to see IN:BALPHARMA full AI Analyst Report?

Bal Pharma Limited (BALPHARMA) Financial Statements

0 Followers

Bal Pharma Limited Financial Overview

Bal Pharma Limited's market cap is currently ₹1.69B. The company's EPS TTM is ₹4.54; its P/E ratio is 23.66; and it has a dividend yield of 1.12%. Bal Pharma Limited is scheduled to report earnings on August 12, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 3.12B₹ 3.03B₹ 3.39B₹ 3.04B₹ 2.81B
Gross Profit₹ 761.52M₹ 730.18M₹ 770.20M₹ 1.25B₹ 1.11B
Operating Income₹ 208.24M₹ 197.89M₹ 214.57M₹ 177.23M₹ 149.18M
EBITDA₹ 338.31M₹ 317.63M₹ 320.23M₹ 245.00M₹ 239.71M
Net Income₹ 62.84M₹ 72.15M₹ 73.92M₹ 25.72M₹ 56.12M
Balance Sheet
Cash & Short-Term Investments₹ 92.92M₹ 105.19M₹ 199.29M₹ 74.63M₹ 60.84M
Total Assets₹ 3.76B₹ 3.36B₹ 3.20B₹ 3.13B₹ 2.61B
Total Debt₹ 1.60B₹ 1.50B₹ 1.42B₹ 1.33B₹ 1.07B
Net Debt₹ 1.52B₹ 1.42B₹ 1.38B₹ 1.30B₹ 1.06B
Total Liabilities₹ 2.93B₹ 2.58B₹ 2.50B₹ 2.49B₹ 2.02B
Stockholders' Equity₹ 822.27M₹ 774.16M₹ 692.94M₹ 637.89M₹ 586.27M
Cash Flow
Free Cash Flow₹ -40.83M₹ -145.55M₹ 118.26M₹ -164.89M₹ 192.39M
Operating Cash Flow₹ 144.72M₹ 42.32M₹ 228.06M₹ -18.43M₹ 277.08M
Investing Cash Flow₹ -215.41M₹ -156.53M₹ -188.91M₹ -221.82M₹ -94.85M
Financing Cash Flow₹ 72.26M₹ 90.12M₹ -12.06M₹ 244.00M₹ -181.34M
Currency in INR

Bal Pharma Limited Earnings and Revenue History

Income Statement >

Bal Pharma Limited Debt to Assets

Balance Sheet >

Bal Pharma Limited Cash Flow

Cash Flow >

Bal Pharma Limited Forecast EPS vs Actual EPS

Earnings >